India said that the COVID-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and Covishield, from Friday.
Biological E's Corbevax will be available to over 18s as precautionary booster six months after a second dose, the health ministry said in an August 8 letter to state authorities and shared with reporters on Wednesday.
Covishield is produced for the Indian market by the Serum Institute of India under licence from AstraZeneca, while Bharat Biotech makes Covaxin.
India has so far administered more than 2 billion COVID vaccine shots, including 113 million boosters, all of which have so far been of the same vaccine as the recipient's first two doses.
The government says about 89 per cent of people above the age of 12 have had two doses.
The country of nearly 1.4 billion people has documented more than 44 million coronavirus infections and 526,826 related deaths.
The actual numbers are believed to be many times higher.
Pakistan jails more than 100 members of ex-PM Imran Khan's party for riots
Trump's envoy Witkoff heads to Israel for Gaza aid, ceasefire push
Canada plans to recognise Palestinian state, raising allies' pressure on Israel
Cambodia asks Thailand to release detained soldiers as truce holds
London's Heathrow hit by more flight cancellations after air traffic failure
US Senate rejects bids to block arms sales to Israel over Gaza
At least 60 dead in north China following extreme rain, authorities say
London flights resume after airports disrupted by radar fault
